詳細検索

詳細検索

お問い合わせ

IDT Australia Ltd (IDT:ASX) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends

IDT Australia Ltd (IDT:ASX) - Strategic SWOT and Financial Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Financial and Operational KPIs, and Recent Trends


Report Summary IDT Australia Ltd Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and... もっと見る

 

 

出版社
Quaintel Research
クアインテルリサーチ
出版年月
2026年6月10日
電子版価格
納期
3-4営業日程度
ページ数
101
言語
英語

日本語のページはAI翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

Report Summary

IDT Australia Ltd Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of IDT Australia Ltd's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about IDT Australia Ltd including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses IDT Australia Ltd's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of IDT Australia Ltd's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers IDT Australia Ltd's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares IDT Australia Ltd's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by IDT Australia Ltd enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

IDT Australia Ltd, founded in 1975, is a Melbourne based Contract Development and Manufacturing Organisation CDMO with over 50 years of experience in pharmaceutical manufacturing. Headquartered in Boronia, Victoria, Australia, the company operates a state of the art 12000m2 cGMP modular facility supporting the production of active pharmaceutical ingredients APIs and finished dosage forms FDFs from milligram scale development through to commercial supply. Its manufacturing capabilities cover high containment and high potency products including controlled S8 and S9 substances, solid and liquid oral doses, and sterile injectables. IDT Australia offers end to end services encompassing laboratory based RD, formulation, process optimisation, GMP manufacturing, analytical and microbiology testing, project management, packaging, labelling, distribution, and regulatory compliance. The company is accredited by the TGA, FDA, MHLW, and recognised across Europe and Canada, with licenses for controlled substances and veterinary medicines. Its sole reportable segment is the development and manufacture of APIs and FDFs, reflecting its integrated service model and global operational footprint.

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a IDT Australia Ltd's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the IDT Australia Ltd's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the IDT Australia Ltd's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the IDT Australia Ltd's internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company IDT Australia Ltd:

• IDT Australia Ltd PESTLE Analysis
• IDT Australia Ltd Value Chain Analysis
• IDT Australia Ltd Porter's Five Forces Analysis
• IDT Australia Ltd VRIO Analysis
• IDT Australia Ltd BCG Analysis
• IDT Australia Ltd Segmentation, Targeting and Positioning (STP) Analysis
• IDT Australia Ltd Ansoff Matrix Analysis

ページTOPに戻る


Table of Contents

Table of Contents 2
Tables 5
Charts 6
IDT Australia Ltd - Key Company Facts 7
IDT Australia Ltd - Company Description 8
IDT Australia Ltd - Top Executives 9
IDT Australia Ltd - Head Office & Locations 10
Head Office - Country 10
IDT Australia Ltd - Products and Services 11
Products 11
Services 12
IDT Australia Ltd - Corporate Strategy 13
IDT Australia Ltd - Business Description 16
API and FDF 16
IDT Australia Ltd - ESG Spotlight 18
Environment 18
Social 19
Corporate Governance 19
IDT Australia Ltd - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 27
Threats 29
IDT Australia Ltd - Financial Deep Dive 31
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 31
Profit and Loss Statement 33
Summary of Profit and Loss Statement 33
Balance Sheet 37
Summary of Balance Sheet 37
Cash Flow Statement 41
Summary of Cash Flow Statement 41
Key Financial Ratio Analysis 45
IDT Australia Ltd - Ratio Charts 47
Activity Ratio Charts 47
Growth Ratios Charts 48
Leverage Ratio Charts 52
Liquidity Ratio Charts 54
Profitability Ratio Charts 56
Competing Players 58
Snapshot of Competing Players 59
Catalent, Inc 59
Key Company Facts 59
Company Description 59
WuXi AppTec Co Ltd 60
Key Company Facts 60
Company Description 60
Key Financials 61
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 61
Key Financial Ratio Analysis 66
Recipharm AB 68
Key Company Facts 68
Company Description 68
Laurus Labs Ltd 69
Key Company Facts 69
Company Description 69
Key Financials 70
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 70
Key Financial Ratio Analysis 75
Neuland Laboratories Ltd 77
Key Company Facts 77
Company Description 77
Key Financials 78
Share Price Trend - Jun-2025 to Jun-2026 (Average Share Closing Price) 78
Key Financial Ratio Analysis 83
Appendix 85
Definitions 85
SWOT Analysis 85
PESTLE Analysis 85
Value Chain Analysis 85
ESG Spotlight 85
Financial Deep Dive 85
Financial Ratios 86
Activity Ratios 86
Growth Ratios 88
Leverage Ratios 91
Liquidity Ratios 93
Market Ratios 95
Profitability Ratios 97
Research Methodology 99
Disclaimer 100
Contact Us 100

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療/ヘルスケア)の最新刊レポート

Quaintel Research社の 医薬品・医療分野 での最新刊レポート

本レポートと同じKEY WORD(corporate)の最新刊レポート


よくあるご質問


Quaintel Research社はどのような調査会社ですか?


Quaintel Researchはインドを拠点をとする調査会社です。 様々な企業の分析を行っており、企業の競合分析に役立つ資料をご提供します。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/08/17 10:26

160.11 円

185.73 円

219.67 円

ページTOPに戻る